Now more than ever, compliance and safety are drivers of innovation

IN LESS than three weeks, on 12 and 13 February 2014, the Pharmapack Europe conference and exhibition will bring together all the leading names in the healthcare industry at Paris Expo at the Porte de Versailles. More than 3,200 visitors and 340 exhibitors originating from more than 70 countries are expected to attend the event in its new venue.

The 13th edition of this leading European event for innovative packaging and delivery systems for medicinal and healthcare products will be held in a new and more spacious location, yet remains dedicated to maintaining its extremely high quality standards.

Pharmapack Europe 2014 will bring together a record number of exhibiting companies, with more than 340 worldwide suppliers specialising in primary, secondary and tertiary packaging as well as drug delivery systems. The exhibition has recorded excellent growth in terms of the number of participants (up 15%) and international representation, with more than 65% of exhibiting companies originating from outside France. There has been a marked increase in participation from Eastern Europe, the USA, the Middle East, North Africa and Asia.

Four conference sessions at Pharmapack Europe 2014 will address topics that are crucial to development strategy and innovation within the healthcare community

High level of technical expertise and innovation

Visitors will be offered a comprehensive overview of the current situation in the sector, with a programme comprising more than 40 semi-scientific conferences. "The presentations attest to a very high level of technical expertise and innovation," observes Franck Pavan, Business Development manager of Aquitaine Pharm International, Pierre Fabre Médicament Production.

Chaired by eminent industrial, institutional and academic experts from all over the world, there will be four conference sessions dedicated to topics that are crucial to development strategy and innovation within the healthcare community.

Drug Delivery and Drug/Device Combination Products This session will review developments in this area, taking into account a number of important aspects. "This session will offer the opportunity to discuss opinions, to gain an overview of regulatory issues to be addressed and the latest innovations in the field, and to understand the coming challenges in terms of production. Major names in the field of delivery devices will be taking part, offering a valuable contribution to discussions and providing information that will be of interest to all participants," emphasises Jo?l Richard, Ph.D., vice-president, Peptides, CMC & Engineering, Ipsen, who will be leading the session with Dr Yves T. Tillet, CEO of White-Tillet Consultants & Experts.

Packaging of Liquid and Injectable Forms These presentations will look at emerging markets for injectables, as well as innovations that facilitate the use of injection devices, and new packaging solutions that offer features suited to the complexity of these products. "Other presentations will address drug-related innovations, relating to drug manufacturing methods and ways of targeting the disease more closely in order to avoid side effects and treatments that have littlSneakers